Human phenylalanine monooxygenase and thioether metabolism

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 1, 2009, Pages 63-67

  Boonyapiwat, Boontarika ^a   Panaretou, Barry ^b   Forbes, Ben ^b   Mitchell, Stephen C ^c   Steventon, Glyn B ^b  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Metabolism; Phenylalanine hydroxylase; Phenylalanine monooxygenase; S carboxymethyl L cysteine; Thioethers

Indexed keywords

CARBOCISTEINE; CYSTEINE DERIVATIVE; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; PHENYLALANINE MONOOXYGENASE; S BUTYLCYSTEINE; S ETHYLCYSTEINE; S PROPYLCYSTEINE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ALLOSTERISM; ARTICLE; CATALYSIS; DRUG METABOLISM; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MICHAELIS CONSTANT; OXYGENATION; ULTRAVIOLET SPECTROSCOPY; XENOBIOTIC METABOLISM;

EID: 58149231200     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.01.0009     Document Type: Article

References (23)

1. Steventon GB, Mitchell SC. The sulphoxidation of S-carboxymethyl- L-cysteine in COPD. Eur Respir J 2006; 27: 865-866.
2. Steventon GB, Mitchell SC. Efficacy of S-carboxymethyl-Lcysteine for otitis media with effusion. Ear Nose Throat J 2006; 85: 296-297.
3. Brandolini L et al. Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs). Eur Cytokine Netw 2003; 14: 20-26.
4. Steventon GB, Mitchell SC. Non-classical drug metabolism enzymes: the curious case of phenylalanine 4-monooxygenase. Letts Drug Design Discov 2006; 3: 405-412.
5. Boonyapiwat B et al. Phenylalanine hydroxylase: possible involvement in the S-oxidation of S-carboxymethyl-L-cysteine. Anal Biochem 2004; 335: 91-97.
6. Boonyapiwat B et al. Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine in HepG2 cells. Drug Metab Drug Inter 2005; 21: 1-18.
7. Goreish AH et al. Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine. Drug Metab Drug Inter 2004; 20: 159-174.
8. Meese CD. S-Carboxymethyl-L-cysteine-(R)- und (S)-sulphoxid. Arch Pharm (Weinheim) 1987; 320: 473-474.
9. Meese CD et al. Synthesis of metabolites of S-carboxymethyl- L-cysteine and S-methyl-L-cysteine and some isotopically labelled (2H, 13C) analogues. Arch Pharm (Weinheim) 1990; 323: 957-965.
10. Bray HG et al. The formation of mercapturic acids. 3. N-acetylation of S-substituted cysteines in the rabbit, rat and guinea pig. Biochem J 1959; 73: 465-473.
11. Bray HG et al. Metabolism of some ω-halogenoalkylbenzenes and related alcohols in the rabbit. Biochem J 1958; 70: 570-579.
12. Damoglou AP et al. The hydrolysis of thermolysin of dipeptide derivatives that contain substituted cysteine. Biochem J 1971; 123: 379-384.
13. Martinez A et al. Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Biochem J 1995; 306: 589-597.
14. Pey AL et al. Specific interaction of the diastereomers 7(R)- and 7(S)- tetrahydrobiopterin with phenylalanine hydroxylase: Implications for understanding primapterinuria and vitiligo. FASEB J 2006; 20: E1451-E1464.
15. Staffeldt B et al. Determination of S-carboxymethyl-L- cysteine and some of its metabolites in urine and serum by highperformance liquid chromatography using fluorescent precolumn labelling. J Chromatogr 1991; 571: 133-147.
16. Kowlessur D et al. Recombinant human phenylalanine hydroxylase: Novel regulatory and structural properties. Arch Biochem Biophys 1996; 333: 85-95.
17. Knappskog M et al. Structure/function relationships in human phenylalanine hydroxylase. Effect of terminal deletions on the oligomerization, activation and cooperativity of substrate binding to the enzyme. Eur J Biochem 1996; 242: 813-821.
18. Perez B et al. Kinetic stability analysis of PKU mutations identified in BH4-responsive patients. Mol Genet Metab 2005; 86: S11-S16.
19. Mitchell SC, Waring RH. The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine. Pharmacol Ther 1989; 43: 237-249.
20. Waring RH, Mitchell SC. The metabolism and elimination of S-carboxymethyl-L-cysteine in man. Drug Metab Dispos 1982; 10: 61-62.
21. Waring RH et al. Cytosolic sulphoxidation of S-carboxymethyl- Lcysteine in mammals. Biochem Pharmacol 1986; 35: 2999-3002.
22. Ariga T, Seki T. Antithrombotic and anticancer effects of garlic-derived sulfur compounds: a review. BioFactors 2006; 26: 93-103.
23. Milner JA. Preclinical perspectives on garlic and cancer. J Nutr 2006; 136: 827S-831S.